Klaudiya Ruvinsky
Internal Medicine · Brooklyn, NYNPI 1649275918
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 383 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,183 and has fallen 98.9% since, to $25 in 2023. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$565
- Amgen$563
- Novo Nordisk$492
- Bayer$452
- GSK$433
- plus $4K from 30 others
What the payments were for
- Food & beverage$7,561100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 71 | $1,198 |
| AstraZeneca | 31 | $565 |
| Amgen(2 entities) | 28 | $563 |
| Novo Nordisk | 26 | $492 |
| Bayer | 11 | $452 |
| GSK | 19 | $433 |
| Amarin Pharma, Inc. | 19 | $385 |
| Novartis | 17 | $371 |
| Pfizer | 17 | $271 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $263 |
| Merck | 14 | $228 |
| Lilly USA, LLC | 12 | $223 |
| Arbor Pharmaceuticals, Inc. | 13 | $218 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $210 |
| Kowa Pharmaceuticals America, Inc. | 10 | $206 |
| E.r. Squibb & Sons, L.L.C. | 12 | $195 |
| Boehringer Ingelheim | 9 | $190 |
| Sanofi | 3 | $170 |
| Nestle Healthcare Nutrition Inc. | 8 | $162 |
| Sunovion Pharmaceuticals Inc. | 6 | $143 |
| Astellas Pharma US Inc | 7 | $140 |
| Bristol Myers Squibb | 6 | $114 |
| Endo Pharmaceuticals Inc. | 2 | $42 |
| Ironwood Pharmaceuticals, Inc | 2 | $42 |
| Johnson & Johnson | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Vivus LLC | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Radius Health, Inc. | 1 | $27 |
| Althera Pharmaceuticals LLC | 2 | $27 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Sobi, Inc | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Vistapharm, Inc. | 1 | $15 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,579 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Jesi RamoneBrooklyn$627K
- Manish ParikhBrooklyn$236K
- Samuel UterBrooklyn$136K
- David DoveEast Hampton$12.3M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.